ThePrintPod: ‘Adulterated drugs’ to breakthrough cancer therapy — how India’s health & pharma sector fared in 2023

The year was eventful with National Medical Commission's flip-flops over controversial decisions, tightening of various norms and launch of made-in-India drugs to treat rare diseases.